Indirect Buyers' Wellbutrin Antitrust Suit Lives On
A federal judge has nixed some state claims and allowed others to stand in an indirect purchaser action accusing GlaxoSmithKline PLC of filing baseless patent suits to delay generic competition over...To view the full article, register now.
Already a subscriber? Click here to view full article